Biofrontera (BFRI) Cash & Current Investments (2020 - 2026)
Biofrontera (BFRI) reported Cash & Current Investments of $4.71 million for Q2 2026, down 35.0% from $7.25 million a year earlier.
Powered by 
Analysis
Biofrontera (BFRI) Cash & Current Investments (2020 - 2026) Analysis & Trends
At the end of FY2025, Biofrontera posted Cash & Current Investments of $6.41 million, up 8.4% from FY2024.
- Cash & Current Investments has a five-year compound annual growth rate of -4.6% (FY2020 to FY2025).
- By year, Cash & Current Investments came in at $5.91 million in FY2024 (+316.0%), $1.42 million in FY2023 (-94.9%), $27.76 million in FY2022 (+13.1%) and $24.55 million in FY2021 (+203.0%).
- Five-year quarterly Cash & Current Investments spans a low of $1.42 million in Q4 2023 and a high of $31.91 million in Q2 2022.
- Year over year, Cash & Current Investments gained in four of the last seven quarters, with growth averaging 35.4%.
- The high point for year-over-year Cash & Current Investments in five years was Q4 2024 (growth of 316.0%); the low point was Q4 2023 (a decline of 94.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Biofrontera | 14.35 Mn | -7.44 Mn | 9.59 Mn | 4.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.71 Mn |
| Dec 31, 2025 | 6.41 Mn |
| Sep 30, 2025 | 3.43 Mn |
| Jun 30, 2025 | 7.25 Mn |
| Mar 31, 2025 | 1.81 Mn |
| Dec 31, 2024 | 5.91 Mn |
| Sep 30, 2024 | 2.91 Mn |
| Jun 30, 2024 | 4.41 Mn |
| Mar 31, 2024 | 3.84 Mn |
| Dec 31, 2023 | 1.42 Mn |
| Sep 30, 2023 | 10.06 Mn |
| Mar 31, 2023 | 8.90 Mn |
| Dec 31, 2022 | 27.76 Mn |
| Sep 30, 2022 | 27.52 Mn |
| Jun 30, 2022 | 31.91 Mn |
| Mar 31, 2022 | 22.43 Mn |
| Dec 31, 2021 | 24.55 Mn |
| Sep 30, 2021 | 1.72 Mn |
| Dec 31, 2020 | 8.10 Mn |
API Access
Biofrontera Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=BFRI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "BFRI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=BFRI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();